240 related articles for article (PubMed ID: 32711296)
21. Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient.
Guillan M; Villacieros-Alvarez J; Bellido S; Perez-Jorge Peremarch C; Suarez-Vega VM; Aragones-Garcia M; Cabrera-Rojo C; Fernandez-Ferro J
Thromb Res; 2020 Sep; 193():107-109. PubMed ID: 32534327
[TBL] [Abstract][Full Text] [Related]
22. COVID-19: 10 things I wished I'd known some months ago.
Pickkers P; van der Hoeven H; Citerio G
Intensive Care Med; 2020 Jul; 46(7):1449-1452. PubMed ID: 32494929
[No Abstract] [Full Text] [Related]
23. Clinical features of covid-19.
Vetter P; Vu DL; L'Huillier AG; Schibler M; Kaiser L; Jacquerioz F
BMJ; 2020 Apr; 369():m1470. PubMed ID: 32303495
[No Abstract] [Full Text] [Related]
24. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
25. New type of corona virus induced acute otitis media in adult.
Fidan V
Am J Otolaryngol; 2020; 41(3):102487. PubMed ID: 32336572
[TBL] [Abstract][Full Text] [Related]
26. First motor seizure as presenting symptom of SARS-CoV-2 infection.
Fasano A; Cavallieri F; Canali E; Valzania F
Neurol Sci; 2020 Jul; 41(7):1651-1653. PubMed ID: 32417987
[No Abstract] [Full Text] [Related]
27. Familial cluster of COVID-19 infection from an asymptomatic.
Zhang J; Tian S; Lou J; Chen Y
Crit Care; 2020 Mar; 24(1):119. PubMed ID: 32220236
[No Abstract] [Full Text] [Related]
28. Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide.
Bollo L; Guerra T; Bavaro DF; Monno L; Saracino A; Angarano G; Paolicelli D; Trojano M; Iaffaldano P
J Neurol Sci; 2020 Sep; 416():117011. PubMed ID: 32650143
[No Abstract] [Full Text] [Related]
29. The COVID-19 Pandemic and Mayo Clinic Proceedings.
Nath KA
Mayo Clin Proc; 2020 May; 95(5):835-836. PubMed ID: 32370843
[No Abstract] [Full Text] [Related]
30. Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration.
Racke MK; Newsome SD
J Neuroimmunol; 2020 Aug; 345():577283. PubMed ID: 32518058
[No Abstract] [Full Text] [Related]
31. Co-infection with SARS-CoV-2 and Human Metapneumovirus.
Touzard-Romo F; Tapé C; Lonks JR
R I Med J (2013); 2020 Mar; 103(2):75-76. PubMed ID: 32192233
[TBL] [Abstract][Full Text] [Related]
32. Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
Valero-López G; Carreón-Guarnizo E; Hernández-Clares R; Iniesta-Martínez F; Jiménez-Veiga J; Moreno-Docon A; Iborra-Bendicho MA; Aznar-Robles E; Hellín-Gil MF; Morales-Ortiz A; Meca-Lallana JE
Neurologia (Engl Ed); 2020; 35(6):357-362. PubMed ID: 32591152
[TBL] [Abstract][Full Text] [Related]
33. [Pediatric impact of COVID-19].
L'Huillier AG; Asner SA
Rev Med Suisse; 2020 Apr; 16(N° 691-2):839-841. PubMed ID: 32348048
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
[No Abstract] [Full Text] [Related]
35. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Rejdak K; Grieb P
Mult Scler Relat Disord; 2020 Jul; 42():102163. PubMed ID: 32388458
[TBL] [Abstract][Full Text] [Related]
36. SARS-Coronavirus-2 and acute urticaria.
Falkenhain-López D; Sánchez-Velázquez A; López-Valle A; Ortiz-Frutos FJ
Int J Dermatol; 2020 Jul; 59(7):867-868. PubMed ID: 32441802
[No Abstract] [Full Text] [Related]
37. Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis.
Salama S; Giovannoni G; Hawkes CH; Lechner-Scott J; Waubant E; Levy M
Mult Scler Relat Disord; 2020 Jul; 42():102259. PubMed ID: 32571580
[No Abstract] [Full Text] [Related]
38. Modified Wake Forest Type Protective Shield for an Asymptomatic, COVID-19 Nonconfirmed Patient for Intubation Undergoing Urgent Surgery.
Kinjo S; Dudley M; Sakai N
Anesth Analg; 2020 Aug; 131(2):e127-e128. PubMed ID: 32398427
[No Abstract] [Full Text] [Related]
39. Different outcome of COVID-19 in members of a family.
Sun J; Jiang Y; Lin W; Hu WH; Wang Y
J Infect Dev Ctries; 2020 May; 14(5):447-449. PubMed ID: 32525829
[TBL] [Abstract][Full Text] [Related]
40. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
Uvais NA
Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
